NCT00028730
- Conditions
- Bone Marrow Diseases, Burkitt Lymphoma, Chronic Disease, +31 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Clinical trial condition
Histiocytic Disorders, Malignant
Explore clinical trials studying Histiocytic Disorders, Malignant. Study availability and eligibility vary by location and protocol.
260 public trials
43 recruiting studies
Histiocytic Disorders, Malignant trial results
NCT00161187
- Conditions
- Adenocarcinoma, Adnexal Diseases, Blast Crisis, +151 more
- Locations
-
- Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States
NCT00134004
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +63 more
- Locations
-
- Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
- Hahnemann University Hospital Philadelphia, Pennsylvania, United States
NCT00324779
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +19 more
- Locations
-
- Kinderklinik - Universitaetsklinikum Aachen Aachen, Germany
- Klinikum Augsburg Augsburg, Germany
- Charite - Campus Charite Mitte Berlin, Germany
- Helios Klinikum Berlin Berlin, Germany
NCT01959477
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +202 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00003414
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
Completed
LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma
NCT00085150
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +31 more
- Locations
-
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
- Doernbecher Children's Hospital at Oregon Health & Science University Portland, Oregon, United States
NCT00020111
- Conditions
- Bone Marrow Diseases, Burkitt Lymphoma, Chronic Disease, +30 more
- Locations
-
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
NCT00343798
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, +145 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
- University of Colorado Denver, Colorado, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma
NCT00099255
- Conditions
- Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +14 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California at Los Angeles Los Angeles, California, United States
- Stanford University Stanford, California, United States
- Yale New Haven, Connecticut, United States